FINANCIALS

TARS Tarsus Pharmaceuticals Inc 1819790

Income Statement
Revenue	tars-20240930	48,118,000
Net Income	tars-20240930	-23,420,000
Profit Margin		-48.67%

Balance Sheet
Current Assets	357,117,000
Assets	376,300,000
Current Liabilities	65,868,000
Liabilities	138,816,000
Equity	237,484,000
Shares Out	38,042,000

Cash Flow Statement
Operating Cash Flow	-60,845,000
Investing Cash Flow	-139,621,000

Market Analysis
Market Cap	1,183,478,243
Price	46.52
BVPS	6.24
PB	7.38
EPS	-4.43
PS	6.15
FCF	-200,466,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view TARS documents filed with the SEC.

TARS Filings Clear

View A List of Tickers